Human immunodeficiency virus infection in end-stage renal disease patients

被引:30
|
作者
Rao, TKS [1 ]
机构
[1] SUNY Downstate Med Ctr, Dept Med, Brooklyn, NY USA
关键词
D O I
10.1046/j.1525-139X.2003.16047.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Human immunodeficiency virus (HIV) infection in patients with end-stage renal disease (ESRD) offers many diagnostic and therapeutic challenges to nephrologists. Renal failure may be a direct consequence of viral infection (HIV-associated nephropathy), or intrinsic renal diseases may occur in previously infected individuals. Patients receiving renal replacement therapy (RRT) may acquire HIV infection from blood transfusions, renal allografts, sexual contacts, or needle sharing by drug addicts. In the early 1980s, the overall prognosis of patients with the acquired immunodeficiency syndrome (AIDS) was very poor, and survival of those with ESRD was dismal. Consequently many even questioned the value of providing maintenance dialysis to patients with AIDS. With advances in diagnostic techniques in serologic and viral markers of disease, and deployment of highly effective antiretroviral agents, the prognosis of HIV-infected patients has dramatically improved. Over the past two decades, experiences in the management of HIV patients with ESRD is accumulating. Both peritoneal dialysis and hemodialysis are effective modes of therapy and many centers are now beginning to perform renal transplantation in HIV-infected patients. This article deals with various aspects of HIV infection in patients with ESRD.
引用
收藏
页码:233 / 244
页数:12
相关论文
共 50 条
  • [1] Declining incidence of end-stage renal disease (ESRD) complicating human immunodeficiency virus (HIV) infection
    Rao, T.K.S.
    Friedman, E.A.
    [J]. ASAIO Journal, 2000, 46 (02)
  • [2] Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
    Bica, I
    McGovern, B
    Dhar, R
    Stone, D
    McGowan, K
    Scheib, R
    Snydman, DR
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) : 492 - 497
  • [3] Hepatitis C virus infection in patients with end-stage renal disease
    Wigneswaran, John
    Van Wyck, David
    Pegues, David
    Gholam, Pierre
    Nissenson, Allen R.
    [J]. HEMODIALYSIS INTERNATIONAL, 2018, 22 (03) : 297 - 307
  • [4] INCIDENCE AND RISK FACTORS OF SELECT MALIGNANCIES IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS AND END-STAGE RENAL DISEASE
    Patel, M.
    Waller, J.
    Baer, S.
    Spearman, V.
    Kheda, M.
    Young, L.
    Nahman, S.
    Colombo, R.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 581 - 581
  • [5] Treatment of hepatitis C virus infection in patients with end-stage renal disease
    Liu, Chen-Hua
    Kao, Jia-Horng
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (02) : 228 - 239
  • [6] Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: Has the outcome changed in the 1990s?
    Ifudu, O
    Mayers, JD
    Matthew, JJ
    Macey, LJ
    Brezsnyak, W
    Reydel, C
    McClendon, E
    Surgrue, T
    Rao, TKS
    Friedman, EA
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (04) : 549 - 552
  • [7] HBV infection in patients with end-stage renal disease
    Fabrizi, F
    Bunnapradist, S
    Martin, P
    [J]. SEMINARS IN LIVER DISEASE, 2004, 24 : 63 - 70
  • [8] TT virus infection in end-stage renal disease (ESRD)
    Fabrizi, F
    Martin, P
    Lunghi, G
    Locatelli, F
    [J]. JOURNAL OF NEPHROLOGY, 2001, 14 (02) : 80 - 87
  • [9] Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease
    Neff, GW
    Bonham, A
    Tzakis, AG
    Ragni, M
    Jayaweera, D
    Schiff, EK
    Shakil, O
    Fung, JJ
    [J]. LIVER TRANSPLANTATION, 2003, 9 (03) : 239 - 247
  • [10] Hepatitis C virus infection and its treatment in patients with end-stage renal disease
    Rostaing, Lionel
    Alric, Laurent
    Izopet, Jacques
    Kamar, Nassim
    [J]. SEMINARS IN DIALYSIS, 2014, 27 (05) : 451 - +